Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective carboxylate production from detoxified lignocellulosic prehydrolysates through bioaugmented anaerobic fermentation.

RSC advances·2026
Same author

Ischemic stroke despite direct oral anticoagulation: what is hidden?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2024
Same author

Mediterranean springs: Keystone ecosystems and biodiversity refugia threatened by global change.

Global change biology·2023
Same author

Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin.

The Journal of antimicrobial chemotherapy·2023
Same author

Bioinspired gelatin/bioceramic composites loaded with bone morphogenetic protein-2 (BMP-2) promote osteoporotic bone repair.

Biomaterials advances·2022
Same author

Role of changes in plasma prolactin concentrations on ram and buck sperm cryoresistance.

Domestic animal endocrinology·2021
Same journal

Thymidylate synthase inhibitory drugs induce p53-dependent pathways differently.

PloS one·2026
Same journal

Top-down and bottom-up attention for joint pattern classification and reconstruction.

PloS one·2026
Same journal

Short- and long-term scaling behavior of blood pressure and pulse arrival time during sleep in healthy controls and patients with obstructive sleep apnea.

PloS one·2026
Same journal

Double DQN-based secrecy energy efficiency and fairness performance in IRS-assisted NOMA systems with friendly jamming.

PloS one·2026
Same journal

10 recommendations for strengthening citizen science for improved societal and ecological outcomes: A co-produced analysis of challenges and opportunities in the 21st century.

PloS one·2026
Same journal

Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.

PloS one·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

3.2K

Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas.

A G de Lucas1, A J Schuhmacher2, M Oteo1

  • 1Biomedical Application of Radioisotopes Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Madrid, Spain.

Plos One
|July 28, 2016
PubMed
Summary
This summary is machine-generated.

We developed a novel immunoPET tracer, 89Zr-DFO-LEM2/15, targeting Membrane-type 1 matrix metalloproteinase (MT1-MMP). This tracer enables specific, noninvasive imaging of Glioblastoma Multiforme (GBM) tumors, showing high potential for improved diagnosis and monitoring.

More Related Videos

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

9.5K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.2K

Related Experiment Videos

Last Updated: Mar 17, 2026

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
07:25

Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment

Published on: March 1, 2024

3.2K
Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
07:52

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts

Published on: April 26, 2018

9.5K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.2K

Area of Science:

  • Oncology
  • Radiochemistry
  • Molecular Imaging

Background:

  • Glioblastoma Multiforme (GBM) presents significant diagnostic and monitoring challenges.
  • Membrane-type 1 matrix metalloproteinase (MT1-MMP) is a key biomarker for GBM progression, correlating with tumor grade and patient prognosis.
  • Noninvasive imaging of MT1-MMP is crucial for effective GBM management.

Purpose of the Study:

  • To develop and validate a novel immunoPET tracer targeting MT1-MMP for GBM detection.
  • To assess the efficacy of the MT1-MMP-targeted tracer in preclinical GBM models.
  • To evaluate the tracer's performance in relation to blood-brain barrier (BBB) disruption.

Main Methods:

  • Conjugation of an anti-MT1-MMP monoclonal antibody (mAb) LEM2/15 to DFO-NCS for 89Zr labeling, creating 89Zr-DFO-LEM2/15.
  • Biodistribution and Positron Emission Tomography (PET) imaging studies in mice bearing human GBM xenografts (U251) and breast carcinoma cells (MCF-7).
  • PET imaging in orthotopic GBM models (TS543 and U251) with varying degrees of BBB disruption.

Main Results:

  • Efficient synthesis of 89Zr-DFO-LEM2/15 with high yield (>90%) and specific activity.
  • Demonstrated specific and prominent uptake of the tracer in MT1-MMP-positive GBM tumors compared to controls.
  • Tracer penetration into orthotopic GBM models was highly dependent on BBB disruption, with higher accumulation in tumors with a more disrupted BBB.

Conclusions:

  • Successfully synthesized and validated 89Zr-DFO-LEM2/15 as an effective immunoPET tracer for MT1-MMP.
  • The tracer enables high-specific-contrast in vivo imaging of MT1-MMP-positive GBM tumors.
  • MT1-MMP-targeted immunoPET offers a promising alternative to non-specific GBM imaging.